Possible clinical failure of artemether-lumefantrine uncomplicated falciparum malaria

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 3, Issue 1, 2011, Pages

  Repetto, Ernestina C ^a   Traverso, Antonio ^a   Giacomazzi, Claudio G ^a  

^a U Parini Regional Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927569923     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2011.041     Document Type: Article

References (10)

1. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004 Jan 3;363(9402):9-17. http://dx.doi.org/10.1016/S0140-6736(03)15162-8
2. Mutabingwa TK. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! Acta Trop. 2005 Sep;95(3):305-15. http://dx.doi.org/10.1016/j.actatropica.2005.06.009 PMid:16098946
3. World Health Organization 2005: malaria control policies and strategies. World Malaria Report 2005. p14-17.
4. van Agtmael M, Bouchaud O, Malvy D, Delmont J, Danis M, Barette S, Gras C, Bernard J, Touze JE, Gathmann I, Mull R. The comparative efficacy and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France. Int J Antimicrob Agents. 1999 Jul;12(2):159-69. http://dx.doi.org/10.1016/S0924-8579(99)00070-9
5. Ashley EA, Stepniewska K, LindegãYrdh N, Annerberg A, Kham A, Brockman A, Singhasivanon P, White NJ, Nosten F. How much fat is necessary to optimize lumefantrine oral bioavailability? Trop Med Int Health. 2007 Feb;12(2):195-200. http://dx.doi.org/10.1111/j.1365-3156.2006.01784.x
6. Mizuno Y, Kato Y, Kudo K, Kano S. First case of treatment failure of artemether- lumefantrine in a Japanese traveler with imported falciparum malaria Jpn J Infect Dis. 2009 Mar;62(2):139-41. PMid:19305055
7. Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, Bostos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L Pyronaridine-artsunate Study Team. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Lancet. 2010 Apr 24;375(9724):1457-67. http://dx.doi.org/10.1016/S0140-6736(10)60322-4
8. World Health Organization 2010: global report on antimalarial drug efficacy and drug resistance: 2000-2010. p36-40.
9. Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, Ashley E, Lee SJ, White NJ. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an openlabel randomised trial. Lancet Infect Dis. 2010 Oct;10(10):673-81. http://dx.doi.org/10.1016/S1473-3099(10)70187-0
10. Yavo W, Faye B, Kuete T, Djohan V, Oga SA, Kassi RR, Diatta M, Ama MV, Tine R, Ndiaye JL, Evi JB, Same-Ekobo A, Faye O, Kone M. Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemetherlumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Malar J. 2011 Jul 20;10(1):198. http://dx.doi.org/10.1186/1475-2875-10-198 PMid:21774826 PMCid:3164625